xanthenes has been researched along with Cerebral Amyloid Angiopathy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Backhaus, R; Bauer, B; Bogdahn, U; Boy, S; Hartz, AM; Klünemann, HH; Mihaljevic, I; Schlachetzki, F; Schuierer, G; Soldner, EL; Wolf, A | 1 |
1 other study(ies) available for xanthenes and Cerebral Amyloid Angiopathy
Article | Year |
---|---|
Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apolipoproteins E; Blood-Brain Barrier; Blotting, Western; Capillaries; Cell Membrane; Cerebral Amyloid Angiopathy; Cerebral Hemorrhage; Female; Fluorescent Dyes; Hemosiderosis; Humans; Magnetic Resonance Imaging; Male; Matrix Metalloproteinases; Mice; Mice, Transgenic; Middle Aged; Patient Selection; Phenotype; Stroke; Tight Junctions; Tomography, X-Ray Computed; Xanthenes | 2012 |